<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta />
    <article-meta>
      <title-group>
        <article-title>OpenPVSignal Knowledge Graph: An openly available data source for pharmacovigilance signal reports</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>Achilleas Chytas</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Pantelis Natsiavas</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <aff id="aff0">
          <label>0</label>
          <institution>Centre for Research and Technology Hellas</institution>
        </aff>
        <aff id="aff1">
          <label>1</label>
          <institution>Institute of Applied Biosciences</institution>
          ,
          <addr-line>6th km Charilaou-Thermi 570 01, Thessaloniki</addr-line>
          ,
          <country country="GR">Greece</country>
        </aff>
      </contrib-group>
      <abstract>
        <p>Pharmacovigilance (PV) Signal Reports (SRs) are the consolidation of numerous Individual Case Safety Reports (ICSRs) by experts for the early detection of causal relationships between Drugs and Adverse Drug Reactions using statistical correlations. These reports currently exist in a format not useable by Information and Communications Technology (ICT) systems. OpenPVSignal model was an effort to bridge the gap between the SRs and ICTs by converting them to OWL/RDF format. This paper presents the resulting data from the conversion of 108 SRs using OpenPVSignal as the base data model.</p>
      </abstract>
      <kwd-group>
        <kwd>1 Semantic Web</kwd>
        <kwd>Real-World Data</kwd>
        <kwd>Pharmacovigilance</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec-1">
      <title>1. Introduction</title>
    </sec>
    <sec id="sec-2">
      <title>2. Methodology</title>
      <p>The WHO-UMC data conversion to OWL/RDF has been an iterative process including multiple
steps of data quality and validation while a set of researchers that consisted of 4 knowledge engineers
and 2 domain experts (one pharmacologist and one physician) were involved in the process. Only a few
signals were excluded because they did not focus on drug-ADR interactions, but rather incorrect drug
usage or labelling. Figure 1 depicts a PVSR of the presented KG. The KG is openly available to
download in Turtle syntax at a GitHub repository https://github.com/inab-certh/OpenPVSignal along
with the methodology used for the data validation, while an openly published in a live RDF triple store
exists to support exploration http://snf-893389.vm.okeanos.grnet.gr:7200/login.
15th International SWAT4HCLS Conference, February 26-29, 2024, Leiden, The Netherlands
EMAIL: achytas@certh.gr (A. 1); nbassili@csd.auth.gr (A. 2); pnatsiavas@certh.gr (A.3)
ORCID: 0000-0001-8486-011X (A. 1); 0000-0001-6035-1038 (A. 2); 0000-0002-4061-9815 (A. 3)
️© 2024 Copyright for this paper by its authors.</p>
      <p>Use permitted under Creative Commons License Attribution 4.0 International (CC BY 4.0).</p>
      <p>CEUR Workshop Proceedings (CEUR-WS.org)</p>
    </sec>
    <sec id="sec-3">
      <title>3. Discussion</title>
      <p>OpenPVSignal is an open data source that consists of PVSRs in a FAIR
(Findable-AccessibleInteroperable-Reusable) compliant format. Having these data available in a FAIR format could promote
their systematic reuse and their integration within ICT systems and research pipelines. Additionally, the
OWL semantics along with the rationale of symbolic AI can enable automatic reasoning upon them,
further enhancing their potential by uncovering latent relationships among their Drug and Disease
elements. Thus, the OpenPVSignal KG could play a prominent role in improving the early detection
but also regarding the identification of underlying mechanisms of newly reported ADRs.</p>
    </sec>
    <sec id="sec-4">
      <title>4. References</title>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <mixed-citation>
          1.
          <string-name>
            <surname>Lindquist</surname>
            <given-names>M.</given-names>
          </string-name>
          <article-title>VigiBase, the WHO Global ICSR Database System: Basic Facts</article-title>
          .
          <source>Drug Information Journal. 2008 Sep</source>
          <volume>1</volume>
          ;
          <issue>42</issue>
          (
          <issue>5</issue>
          ):
          <fpage>409</fpage>
          -
          <lpage>19</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref2">
        <mixed-citation>
          2.
          <string-name>
            <surname>Natsiavas</surname>
            <given-names>P</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Boyce</surname>
            <given-names>RD</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Jaulent</surname>
            <given-names>MC</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Koutkias</surname>
            <given-names>V.</given-names>
          </string-name>
          <article-title>OpenPVSignal: Advancing Information Search, Sharing and Reuse on Pharmacovigilance Signals via FAIR Principles and Semantic Web Technologies</article-title>
          . Frontiers in Pharmacology [Internet].
          <year>2018</year>
          [
          <article-title>cited 2023 Mar 1];9</article-title>
          . Available from: https://www.frontiersin.org/articles/10.3389/fphar.
          <year>2018</year>
          .00609
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>